Dr. Thomas Schulze, Co-Founder and Advisor to the CEO of FundamentalPharma GmbH

Thomas is co-founder and has been CEO of FundaMental Pharma GmbH since its inception in 2016. With the recent appointment of his successor, Dr. Dirk Beher, he was appointed to the Board of Directors and became the advisor to the CEO. He also serves as Managing Director at EirGenix Europe GmbH, a company he founded as the international subsidiary of EirGenix Inc. in Taiwan, where he serves as Managing Director. Prior to his tenure at EirGenix he started Formyon where he initially held the CEO position.

Thomas has 35 years of experience in the pharmaceutical and biotechnology industry. He has held CEO, C-level and senior management positions at private and publicly traded biopharmaceutical companies covering a broad range of applications from drug discovery and development to nanotechnology, product authentication and molecular diagnostics. He is passionate about starting companies and building stories in the life sciences world with the goal of making a tangible contribution to the community and people's health.